Is mid-gestational uterine artery Doppler still useful in a setting with routine first-trimester pre-eclampsia screening? A cohort study.
First-trimester pre-eclampsia screening
hypertensive disorders of pregnancy
placenta-related adverse outcomes
small for gestational age
stillbirth
uterine artery Doppler
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
28
12
2022
received:
03
10
2022
accepted:
21
01
2023
medline:
12
7
2023
pubmed:
1
3
2023
entrez:
28
2
2023
Statut:
ppublish
Résumé
To evaluate whether routine mid-gestational uterine artery Doppler (UtAD) modifies the risk for preterm pre-eclampsia after first-trimester combined pre-eclampsia screening. Retrospective cohort study. London Tertiary Hospital. A cohort of 7793 women with singleton pregnancies, first-trimester pre-eclampsia screening using the Fetal Medicine Foundation (FMF) algorithm and UtAD pulsatility index (PI) assessment at the mid-gestation ultrasound. Pregnancies were divided into four groups: high risk in both trimesters (H Small for gestational age (SGA), hypertensive disorders of pregnancy (HDP) and stillbirth. In this cohort, 600 (7.7%) and 620 (7.9%) women were designated as being at high risk in the first and second trimesters, respectively. Preterm pre-eclampsia was more prevalent in the H Pre-eclampsia risk after first-trimester FMF pre-eclampsia screening may be stratified through mid-gestational routine UtAD assessment. Pregnancy care should not be de-escalated for low mid-gestational UtAD resistance in women classified as being at high risk in the first trimester. The escalation of care may be justified in women at low risk but with high mid-gestational UtAD resistance.
Identifiants
pubmed: 36852521
doi: 10.1111/1471-0528.17441
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1128-1134Informations de copyright
© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Références
Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019;393:1807-18.
NICE. Overview | Hypertension in pregnancy: diagnosis and management | Guidance | NICE. NICE.org.uk. [cited 2022 Aug 18]. Available from: www.nice.org.uk/guidance/ng133
Overview | Antenatal care | Guidance | NICE. [cited 2022 Aug 18]; Available from: https://www.nice.org.uk/guidance/ng201
Elawad T, Scott G, Bone JN, Elwell H, Lopez CE, Filippi V, et al. Risk factors for pre-eclampsia in clinical practice guidelines: comparison with the evidence. BJOG. 2022;00:1-17. https://doi.org/10.1111/1471-0528.17320
Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51:743-50.
Guy GP, Leslie K, Diaz Gomez D, Forenc K, Buck E, Khalil A, et al. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study. BJOG. 2021;128:149-56.
RCOG. RCOG.org.uk. [cited 2022 Aug 18]. Available from: https://www.rcog.org.uk/media/t3lmjhnl/gtg_31.pdf
Papageorghiou AT, Yu CKH, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2004;18:383-96.
Cnossen JS, Morris RK, ter Riet G, Mol BWJ, van der Post JAM, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178:701-11.
Familiari A, Bhide A, Morlando M, Scala C, Khalil A, Thilaganathan B. Mid-pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small-for-gestational-age birth. Acta Obstet Gynecol Scand. 2016;95:238-44.
Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:138-46.
Rolnik DL, Wright D, Poon LCY, Syngelaki A, O'Gorman N, de Paco Matallana C, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50:492-5.
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52:52-9.
Liu B, Frick A, Bhide A, Thilaganathan B. Placental dysfunction screening and perinatal loss. BJOG. 2022;129:1617-8.
Guy GP, Leslie K, Diaz Gomez D, Forenc K, Buck E, Bhide A, et al. Effect of routine first-trimester combined screening for pre-eclampsia on small-for-gestational-age birth: secondary interrupted time series analysis. Ultrasound Obstet Gynecol. 2022;59:55-60.
Papastefanou I, Nowacka U, Buerger O, Akolekar R, Wright D, Nicolaides KH. Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model. BJOG. 2021;128:2110-5.
Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2018;52:186-95.
Noël L, Guy GP, Jones S, Forenc K, Buck E, Papageorghiou AT, et al. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-a or placental growth factor? Ultrasound Obstet Gynecol. 2021;58:540-5.
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613-22.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:110-20.e6.
Bhide A, Acharya G, Baschat A, Bilardo CM, Brezinka C, Cafici D, et al. ISUOG practice guidelines (updated): use of Doppler velocimetry in obstetrics. Ultrasound Obstet Gynecol. 2021;58:331-9.
Gómez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32:128-32.
Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:S1071-97.e2.
García B, Llurba E, Valle L, Gómez-Roig MD, Juan M, Pérez-Matos C, et al. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2016;47:680-9.
Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Am J Obstet Gynecol. 2016;214:619.e1-17.
Liu B, Nadeem U, Frick A, Alakaloko M, Bhide A, Thilaganathan B. Reducing health inequality in black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality. BJOG. 2022;129:1750-6.
Ridder A, Giorgione V, Khalil A, Thilaganathan B. Preeclampsia: the relationship between uterine artery blood flow and trophoblast function. Int J Mol Sci. 2019;20:3263.
Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? Am J Obstet Gynecol. 2022;226:S954-62.
Yu CKH, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH, The Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol. 2003;22:233-9.
Poon LC, Magee LA, Verlohren S, Shennan A, Dadelszen P, Sheiner E, et al. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). Int J Gynaecol Obstet. 2021;154(Suppl 1):3-31.